RxDoctor Payments Data

David Henry

Physician Assistant · Cicero, INNPI 1003215047

Payments from drug & device makers

$344in general payments, 2019–2025

Across 19 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dexcom, Inc.$57
  • Lilly USA, LLC$57
  • Supernus Pharmaceuticals, Inc.$49
  • Novo Nordisk$49
  • GSK$42
  • Stryker$24
  • plus $66 from 5 others

What the payments were for

  • Food & beverage$344100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$344 in reported general payments places this provider in the 55th percentile of 1,955 physician assistant providers in Indiana.

See all physician assistant providers in Indiana

Medicare billing

Part B allowed, 2024
$58,346
Medicare patients
167
Services billed
1,327

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide65$101,359
TrulicityDulaglutide42$67,796
JardianceEmpagliflozin51$55,145
Tresiba Flextouch U-200Insulin Degludec34$49,893
Trelegy ElliptaFluticasone/Umeclidin/Vilanter49$47,743
EliquisApixaban37$32,555
MounjaroTirzepatide24$28,053
JanuviaSitagliptin Phosphate18$16,125
LinzessLinaclotide25$15,227
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog13$11,765
Spiriva HandihalerTiotropium Bromide19$11,646
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr15$6,993
Lantus SolostarInsulin Glargine,hum.Rec.Anlog39$5,085
Dexlansoprazole DrDexlansoprazole11$3,820
Pregabalin71$3,339

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$49$101,35965 claims
Lilly USA, LLCTrulicity, Mounjaro$57$95,85066 claims
GSKTrelegy Ellipta, Anoro Ellipta$42$54,73664 claims
AbbVieLinzess$14$15,22725 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,955 physician assistant providers in Indiana.

Other physician assistant in Cicero

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →